Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study.

Drago JZ, Lawrence D, Livingstone E, Zimmer L, Chen T, Giobbie-Hurder A, Amann VC, Mangana J, Siano M, Zippelius A, Dummer R, Goldinger SM, Sullivan RJ.

Melanoma Res. 2019 Feb;29(1):65-69. doi: 10.1097/CMR.0000000000000527.

PMID:
30376465
2.

Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.

Ma Q, Dieterich LC, Ikenberg K, Bachmann SB, Mangana J, Proulx ST, Amann VC, Levesque MP, Dummer R, Baluk P, McDonald DM, Detmar M.

Sci Adv. 2018 Aug 8;4(8):eaat4758. doi: 10.1126/sciadv.aat4758. eCollection 2018 Aug.

3.

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome).

Mangana J, Guenova E, Kerl K, Urosevic-Maiwald M, Amann VC, Bayard C, Dummer R, French LE.

Case Rep Dermatol. 2017 Mar 21;9(1):74-79. doi: 10.1159/000458752. eCollection 2017 Jan-Apr.

4.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.

Mangana J, Cheng PF, Kaufmann C, Amann VC, Frauchiger AL, Stögner V, Held U, von Moos R, Michielin O, Braun RP, Levesque MP, Goldinger SM, Dummer R.

Melanoma Res. 2017 Aug;27(4):358-368. doi: 10.1097/CMR.0000000000000359.

5.

Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma.

Amann VC, Hoffmann D, Mangana J, Dummer R, Goldinger SM.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1638-1640. doi: 10.1111/jdv.14268. Epub 2017 May 8.

PMID:
28401596
6.

Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.

Antsiferova M, Piwko-Czuchra A, Cangkrama M, Wietecha M, Sahin D, Birkner K, Amann VC, Levesque M, Hohl D, Dummer R, Werner S.

EMBO Mol Med. 2017 Jan;9(1):27-45. doi: 10.15252/emmm.201606493.

7.

Developments in targeted therapy in melanoma.

Amann VC, Ramelyte E, Thurneysen S, Pitocco R, Bentele-Jaberg N, Goldinger SM, Dummer R, Mangana J.

Eur J Surg Oncol. 2017 Mar;43(3):581-593. doi: 10.1016/j.ejso.2016.10.014. Epub 2016 Nov 5. Review.

8.

Sonidegib for the treatment of advanced basal cell carcinoma.

Ramelyte E, Amann VC, Dummer R.

Expert Opin Pharmacother. 2016 Oct;17(14):1963-8. doi: 10.1080/14656566.2016.1225725. Epub 2016 Aug 29. Review.

PMID:
27538055
9.

Localized Hair Repigmentation in a 91-Year-Old Woman.

Amann VC, Dummer R.

JAMA Dermatol. 2016 Jan;152(1):81-2. doi: 10.1001/jamadermatol.2015.3812. No abstract available.

PMID:
26580485
10.

Hypersomnolence in Wilson Disease.

Amann VC, Maru NK, Jain V.

J Clin Sleep Med. 2015 Nov 15;11(11):1341-3. doi: 10.5664/jcsm.5204.

11.

Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine.

Amann VC, Dreier J, Ignatova D, Kamarashev J, Kerl K, Kempf W, Pascolo S, Dummer R, Cozzio A, Guenova E.

Acta Derm Venereol. 2015 May;95(5):602-3. doi: 10.2340/00015555-2002. No abstract available.

Supplemental Content

Loading ...
Support Center